Table of Contents
ISRN Neurology
Volume 2013 (2013), Article ID 370943, 6 pages
http://dx.doi.org/10.1155/2013/370943
Clinical Study

The Effect of Fluoxetine on Progression in Progressive Multiple Sclerosis: A Double-Blind, Randomized, Placebo-Controlled Trial

1Department of Neurology, University Medical Center Groningen, University of Groningen, Postbus 30.001, 9700 RB Groningen, The Netherlands
2Department of Neurology, Rijnstate Hospital, Postbus 9555, 6800 TA Arnhem, The Netherlands
3Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
4Department of Neurology, Center for Neurosciences, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium

Received 19 March 2013; Accepted 16 April 2013

Academic Editors: D. E. Bulman, C.-M. Chen, G. Meco, and D. Schiffer

Copyright © 2013 Jop Mostert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jop Mostert, Thea Heersema, Manju Mahajan, Jeroen Van Der Grond, Mark A. Van Buchem, and Jacques De Keyser, “The Effect of Fluoxetine on Progression in Progressive Multiple Sclerosis: A Double-Blind, Randomized, Placebo-Controlled Trial,” ISRN Neurology, vol. 2013, Article ID 370943, 6 pages, 2013. doi:10.1155/2013/370943